Δημοσίευση

Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction.

ΤίτλοςCardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction.
Publication TypeJournal Article
Year of Publication2010
AuthorsKanashiro-Takeuchi, R. M., Tziomalos K., Takeuchi L. M., Treuer A. V., Lamirault G., Dulce R., Hurtado M., Song Y., Block N. L., Rick F., Klukovits A., Hu Q., Varga J. L., Schally A. V., & Hare J. M.
JournalProc Natl Acad Sci U S A
Volume107
Issue6
Pagination2604-9
Date Published2010 Feb 9
ISSN1091-6490
Λέξεις κλειδιάAnimals, Blotting, Western, Body Weight, Cardiotonic Agents, Echocardiography, Female, Growth Hormone, Growth Hormone-Releasing Hormone, Heart, Hemodynamics, Immunohistochemistry, Insulin-Like Growth Factor I, Myocardial Infarction, Myocardium, Organ Size, Random Allocation, Rats, Rats, Inbred F344, Receptors, Neuropeptide, Receptors, Pituitary Hormone-Regulating Hormone, Recombinant Proteins
Abstract

Whether the growth hormone (GH)/insulin-like growth factor 1(IGF-1) axis exerts cardioprotective effects remains controversial; and the underlying mechanism(s) for such actions are unclear. Here we tested the hypothesis that growth hormone-releasing hormone (GHRH) directly activates cellular reparative mechanisms within the injured heart, in a GH/IGF-1 independent fashion. After experimental myocardial infarction (MI), rats were randomly assigned to receive, during a 4-week period, either placebo (n = 14), rat recombinant GH (n = 8) or JI-38 (n = 8; 50 microg/kg per day), a potent GHRH agonist. JI-38 did not elevate serum levels of GH or IGF-1, but it markedly attenuated the degree of cardiac functional decline and remodeling after injury. In contrast, GH administration markedly elevated body weight, heart weight, and circulating GH and IGF-1, but it did not offset the decline in cardiac structure and function. Whereas both JI-38 and GH augmented levels of cardiac precursor cell proliferation, only JI-38 increased antiapoptotic gene expression. The receptor for GHRH was detectable on myocytes, supporting direct activation of cardiac signal transduction. Collectively, these findings demonstrate that within the heart, GHRH agonists can activate cardiac repair after MI, suggesting the existence of a potential signaling pathway based on GHRH in the heart. The phenotypic profile of the response to a potent GHRH agonist has therapeutic implications.

DOI10.1073/pnas.0914138107
Alternate JournalProc. Natl. Acad. Sci. U.S.A.
PubMed ID20133784
PubMed Central IDPMC2823907
Grant ListR01-AG025017 / AG / NIA NIH HHS / United States
R01-HL084275 / HL / NHLBI NIH HHS / United States
R01-HL094848 / HL / NHLBI NIH HHS / United States
R01-HL65455 / HL / NHLBI NIH HHS / United States
U54-HL081028 / HL / NHLBI NIH HHS / United States

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.